Mientjes G H, van Ameijden E J, van den Hoek A J, Coutinho R A
Municipal Health Service, Department of Public Health and Environment, Amsterdam, The Netherlands.
AIDS. 1992 Feb;6(2):207-12. doi: 10.1097/00002030-199202000-00012.
We determined pneumonia, endocarditis, hospitalizations and death rates in a group of HIV-infected and non-infected IVDU recruited at low-threshold methadone programmes in Amsterdam, The Netherlands to examine the influence of HIV infection on morbidity and non-AIDS mortality in intravenous drug users (IVDU) without AIDS.
A prospective epidemiologic study among HIV-infected and non-infected IVDU in Amsterdam.
We analysed patients attending the Municipal Health Service of Amsterdam.
The patient group consisted of 197 HIV-seropositive IVDU and 193 HIV-seronegative IVDU as controls.
We analysed incidence rates per person-year of bacterial pneumonia; hospitalizations and non-AIDS mortality; and relative risks for HIV-infected IVDU compared to non-infected IVDU.
The incidence of bacterial pneumonia rose from 0.1 in 1986 to 0.29 in 1989 in HIV-infected IVDU. The overall relative risk for this group was 4.0 (95% confidence interval, 1.7-9.7) compared with non-infected controls. HIV-infected IVDU were more frequently hospitalized for bacterial pneumonia than non-infected IVDU (50 versus 13%). In contrast, non-AIDS mortality rates remained stable for both HIV-infected and non-infected IVDU. HIV seropositivity was not found to be an independent risk factor for non-AIDS mortality.
We found a high and rising incidence of bacterial pneumonia among HIV-infected IVDU in Amsterdam without any consequential rise in non-AIDS mortality. This contrasts with reports from studies conducted in New York City, New York, USA, where bacterial pneumonia-related mortality has been found to increase markedly, coincident with the AIDS epidemic. Early detection of bacterial pneumonia and easy access to both inpatient and outpatient medical care may be important factors in preventing early death due to common bacterial pathogens in IVDU without AIDS.
我们确定了在荷兰阿姆斯特丹低门槛美沙酮项目中招募的一组感染HIV和未感染HIV的注射吸毒者(IVDU)的肺炎、心内膜炎、住院率和死亡率,以研究HIV感染对无艾滋病的静脉吸毒者(IVDU)发病率和非艾滋病死亡率的影响。
对阿姆斯特丹感染HIV和未感染HIV的IVDU进行前瞻性流行病学研究。
我们分析了阿姆斯特丹市卫生服务机构的患者。
患者组由197名HIV血清阳性IVDU和193名HIV血清阴性IVDU作为对照组成。
我们分析了细菌性肺炎的每人年发病率;住院率和非艾滋病死亡率;以及感染HIV的IVDU与未感染HIV的IVDU相比的相对风险。
1986年至1989年,感染HIV的IVDU中细菌性肺炎的发病率从0.1升至0.29。与未感染的对照组相比,该组的总体相对风险为4.0(95%置信区间,1.7 - 9.7)。感染HIV的IVDU因细菌性肺炎住院的频率高于未感染HIV的IVDU(50%对13%)。相比之下,感染HIV和未感染HIV的IVDU的非艾滋病死亡率均保持稳定。未发现HIV血清阳性是导致非艾滋病死亡的独立危险因素。
我们发现阿姆斯特丹感染HIV的IVDU中细菌性肺炎的发病率很高且呈上升趋势,但非艾滋病死亡率并未随之上升。这与美国纽约市进行的研究报告形成对比,在纽约市,与细菌性肺炎相关的死亡率已被发现显著增加,与艾滋病流行同时出现。早期发现细菌性肺炎以及方便获得住院和门诊医疗服务可能是预防无艾滋病的IVDU因常见细菌病原体导致过早死亡的重要因素。